REQUEST A DEMO
Total
USD $0.00
Search more companies

Abnova (Taiwan) Corporation (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Abnova (Taiwan) Corporation Profile Updated: May 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Founded in January 2001, Abnova (Taiwan) Corporation is mainly engaged in the production of proteins and antibodies. The main sources of revenue are the monoclonal antibody, protein and polyclonal antibodies. Main products are exported to Americas, Europe and Asia. In 2004, Abnova began to use IT management experience to get rid of laboratory practices, so that the producing of monoclonal and polyclonal antibodies can be industrialized to increase antibody production. In 2007 Abnova imported shareholders from Oulishi Japan, Dongan investment and Sophia venture. In2008, it began to enter the antibody chip and system development, and expand production of length protein.

Headquarters
9F,No,108,Jhouzih St, Neihu
Taipei City; Taipei City;

Contact Details: Purchase the Abnova (Taiwan) Corporation report to view the information.

Website: http://www.abnova.com

Basic Information
Total Employees:
Purchase the Abnova (Taiwan) Corporation report to view the information.
Outstanding Shares:
Purchase the Abnova (Taiwan) Corporation report to view the information.
Financial Auditors:
Purchase the Abnova (Taiwan) Corporation report to view the information.
Incorporation Date:
January 04, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
6.03%
Purchase this report to view the information.
4.04%
Purchase this report to view the information.
3.04%
Purchase this report to view the information.
1.71%
Purchase this report to view the information.
Subsidiaries
Abnova Holding Corporation (United Kingdom)
100%
核心生醫投資股份有限公司
100%
Company Performance
Financial values in the chart are available after Abnova (Taiwan) Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-8.96%
Total operating revenue
-8.94%
Operating profit (EBIT)
-23.23%
EBITDA
-28%
Net Profit (Loss) for the Period
97.89%
Total assets
-2.6%
Total equity
1.96%
Operating Profit Margin (ROS)
-2.17%
Net Profit Margin
13.74%
Return on Equity (ROE)
1.69%
Quick Ratio
2.67%
Cash Ratio
2.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?